Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

3.95
+0.930030.79%
Post-market: 4.770.8200+20.76%19:59 EST
Volume:76.07M
Turnover:277.81M
Market Cap:3.89B
PE:-9.51
High:3.99
Open:3.14
Low:3.07
Close:3.02
52wk High:4.27
52wk Low:1.83
Shares:984.97M
Float Shares:194.00M
Volume Ratio:3.29
T/O Rate:39.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4153
EPS(LYR):-0.5931
ROE:78.05%
ROA:-36.89%
PB:-7.42
PE(LYR):-6.66

Loading ...

OverviewCompanyNewsFilings

ImmunityBio Announces $80 Million Equity Financing from Institutional Investors in Direct Offering

Reuters
·
Jul 25, 2025

Immunitybio, Inc. Announces Execution of $80 Million Equity Financing From Multiple Institutional Investors

THOMSON REUTERS
·
Jul 25, 2025

Immunitybio Inc - Warrants Could Add $96 Mln in Proceeds

THOMSON REUTERS
·
Jul 25, 2025

ImmunityBio Reports 60% Revenue Increase in Q2 2025, Totaling $26.4 Million, Driven by ANKTIVA Unit Growth

Reuters
·
Jul 25, 2025

Immunitybio Reports 60% Increase in Revenue in Q2 2025, With Year-to-Date Sales of $43 Million and 246% Unit Growth Since J-Code With Regulatory Updates

THOMSON REUTERS
·
Jul 25, 2025

Immunitybio Inc - Q2 2025 Revenue $26.4 Mln

THOMSON REUTERS
·
Jul 25, 2025

Immunitybio Inc - UK Mhra Approves Marketing Authorization Application of Anktiva

THOMSON REUTERS
·
Jul 25, 2025

Los Angeles Times to go public, owner Soon-Shiong says

Reuters
·
Jul 22, 2025

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Nov 04, 2025 Post Market
Financial Report Announcement
Aug 05, 2025 Pre-Market
Financial Report Announcement
May 12, 2025 Pre-Market
Financial Report Announcement
Mar 03, 2025 Pre-Market
Financial Report Announcement
Nov 12, 2024 Pre-Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-9.51
Current
-9.50
Sector Average
18.33%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-9.51
Maximum
-1.26
+1 STD
8.94
Minimum
-162.13
-1 STD
-27.94
Average
-9.50

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.